SCHEMBL22397665

SCHEMBL22397665

COc1c(O)ccc2c1OC(c1ccc(O)c(O)c1)CC2=O

nearest known ligand 0.72

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 3/20 0.72
POLB P06746 3/20 0.72
ALPI P09923 3/20 0.72
GAA P10253 3/20 0.72
MAPT P10636 3/20 0.72
RECQL P46063 2/20 0.72
BLM P54132 1/20 0.72
MCL1 Q07820 1/20 0.72
ATM Q13315 1/20 0.72
CYP19A1 P11511 8/20 0.65
ALPL P05186 2/20 0.60
ALPG P10696 2/20 0.60
PKM P14618 2/20 0.60
MEN1 O00255 1/20 0.60
MITF O75030 1/20 0.60
KMT2A Q03164 1/20 0.60
PTPN1 P18031 2/20 0.55
CYP1A1 P04798 2/20 0.50
CYP1B1 Q16678 2/20 0.50
CA12 O43570 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29402477 0.84 KDM4E (1.00) KDM4EPOLBALPIGAAMAPT
SCHEMBL31436253 0.84 KDM4E (1.00) KDM4EPOLBALPIGAAMAPT
SCHEMBL26034914 0.84 KDM4E (1.00) KDM4EPOLBALPIGAAMAPT
SCHEMBL6503931 0.81 POLB (0.62) KDM4EPOLBALPIGAAMAPT
SCHEMBL19736057 0.80 CYP19A1 (0.62) KDM4EPOLBALPIGAAMAPT
SCHEMBL382208 0.80 CYP19A1 (0.62) KDM4EPOLBALPIGAAMAPT
SCHEMBL17559164 0.80 CYP19A1 (0.65) KDM4EPOLBALPIGAAMAPT
SCHEMBL15453089 0.79 MAPT (0.75) KDM4EPOLBALPIGAAMAPT
SCHEMBL30335258 0.79 CYP19A1 (1.00) CYP19A1PTPN1CYP3A4
SCHEMBL31139349 0.77 CYP19A1 (0.71) KDM4EPOLBALPIGAAMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210196607-A1 COMPOSITION FOR IMPROVING SKIN WHITENING OR AMELIORATING THERMAL SKIN AGING COMPRISING 8-METHOXYBUTIN Hesed Bio Co., Ltd. (KR) 2021-07-01 US disclosed
US-20210196607-A1 COMPOSITION FOR IMPROVING SKIN WHITENING OR AMELIORATING THERMAL SKIN AGING COMPRISING 8-METHOXYBUTIN Hesed Bio Co., Ltd. (KR) 2021-07-01 US disclosed
EP-3705110-A1 COMPOSITION FOR IMPROVING SKIN WHITENING OR AMELIORATING THERMAL SKIN AGING COMPRISING 8-METHOXYBUTIN Hesed Bio Co., Ltd. (KR) 2020-09-09 EP disclosed
CN-111372560-A Composition comprising 8-methoxy fisetin for improving skin lightening or improving skin heat aging 赫赛德生物有限公司 2020-07-03 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210196607-A1 COMPOSITION FOR IMPROVING SKIN WHITENING OR AMELIORATING THERMAL SKIN AGING COMPRISING 8-METHOXYBUTIN TYR, HSPB1, HSPA8 KDM4E 1155/4885POLB 151/4885ALPI 4231/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.